Seljeflot, I <br/><br/>
Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease.  [electronic resource] 

 -  Thrombosis and haemostasis  Jun 2000 
 - 944-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Aged<br/>Antigens, CD--blood<br/>Biomarkers--blood<br/>Blood Coagulation Factors--drug effects<br/>Contraceptive Agents, Female--pharmacology<br/>Coronary Disease--drug therapy<br/>Endothelium, Vascular--cytology<br/>Estradiol--pharmacology<br/>Estrogen Replacement Therapy--methods<br/>Female<br/>Humans<br/>Lipids--blood<br/>Medroxyprogesterone Acetate--pharmacology<br/>Middle Aged<br/>Postmenopause<br/>Time Factors<br/>Tissue Plasminogen Activator--blood<br/>Vascular Cell Adhesion Molecule-1--blood<br/>von Willebrand Factor--drug effects